drugset / Trial / NCT04065295
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
RandomizedParallel-groupSingle-blindTreatment
Summary
The main objectives of the SRD part of this trial are to investigate safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of BI 1356225 in healthy male subjects following oral administration of single rising doses. The main objective of the BA part of this trial will be to explore the influence of food on the bioavailability of tablet fasted versus tablet fed
Timeline
- Start
- 2019-09-09
- Primary completion
- 2019-12-23
- Completion
- 2019-12-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 1356225 | Unknown | — | Oral |
Indications
No indication recorded.